EARLYSTRAND
Live / Applied — Third extension granted (statement of use) (as of 26 Feb 2026)
What this means for you
Not registered yet, but its 27 Nov 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98285962
- Mark type
- Stylized text
- Filed
- 27 Nov 2023
- Published for opposition
- 30 Jul 2024
- Attorney of record
- Michael R. Rizzo
Goods and services
- Class 005 — Pharmaceuticals: Medical diagnostic kits comprising medical diagnostic reagents to be used in exposomic testing; medical diagnostic kits comprising medical diagnostic reagents for diagnosing autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; medical diagnostic reagents and assays for testing hair samples
- Class 009 — Scientific and electric apparatus: Laboratory diagnostic kits comprised of a test tube for specimen collection and a requisition form for use with an analysis device for testing hair samples for diagnosis of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer
- Class 010 — Medical apparatus: Apparatus for exposomic testing for medical purposes; apparatus for analysis of hair samples for medical diagnostic purposes for detecting autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing for detecting autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; medical devices for testing hair samples for diagnostic purposes for detecting autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; medical diagnostic kits comprised of blood collecting, urine collecting, and hair sample collecting tubes for specimen collection and a requisition form for use with an analysis device for testing hair samples for diagnosis of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer
- Class 042 — Scientific and technological services: Medical and scientific research in the fields of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer diagnosis; medical research in the fields of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer treatment and diagnosis; laboratory research in the fields of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; genetic testing for scientific research purposes
- Class 044 — Medical, beauty and agricultural services: Medical diagnostic testing, monitoring and reporting services; medical testing for diagnostic purposes in the fields of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; genetic testing for medical purposes
Owner
- Linus Biotechnology Inc., N Brunswick Township, NJ, US
- Linus Biotechnology Inc., New Rochelle, NY, US
Prosecution history
- 27 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Feb 2026 — SOU EXTENSION 3 GRANTED
- 26 Feb 2026 — SOU EXTENSION 3 FILED
- 26 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 28 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Sept 2025 — SOU EXTENSION 2 GRANTED
- 16 Sept 2025 — SOU EXTENSION 2 FILED
- 16 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 21 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 May 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 May 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 May 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 21 May 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 06 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Mar 2025 — SOU EXTENSION 1 GRANTED